• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育异常痣是葡萄膜黑色素瘤的一个危险因素。

Dysplastic nevi are a risk factor for uveal melanoma.

作者信息

Hammer H, Oláh J, Tóth-Molnár E

机构信息

Department of Ophthalmology, Albert Szent-Györgyi University, Szeged, Hungary.

出版信息

Eur J Ophthalmol. 1996 Oct-Dec;6(4):472-4. doi: 10.1177/112067219600600423.

DOI:10.1177/112067219600600423
PMID:8997595
Abstract

Many studies have characterized the phenotypic features of individuals who are likely to develop cutaneous melanoma. One of the major items included in melanoma risk assessment has been the presence of clinically atypical nevi (dysplastic nevi). This study assessed the number of subjects with dysplastic nevi in groups of patients with uveal melanoma or cutaneous melanoma and in a group of volunteer controls. The SPSS program was used to calculate the odds ratios (hereafter called relative risks; RR) and 95% confidence intervals (C) in melanoma patients and controls. The RR was 4.36 for uveal melanoma (95% Cl 1.84-10.36) and 4.22 for cutaneous melanoma (95% Cl 1.81-9.84). These results suggest that cutaneous dysplastic nevi are a significant risk factor for uveal melanoma.

摘要

许多研究已经描述了可能患皮肤黑色素瘤的个体的表型特征。黑色素瘤风险评估中的一个主要项目是临床上非典型痣(发育异常痣)的存在。本研究评估了葡萄膜黑色素瘤或皮肤黑色素瘤患者组以及一组志愿者对照组中患有发育异常痣的受试者数量。使用SPSS程序计算黑色素瘤患者和对照组的优势比(以下称为相对风险;RR)和95%置信区间(C)。葡萄膜黑色素瘤的RR为4.36(95%CI 1.84 - 10.36),皮肤黑色素瘤的RR为4.22(95%CI 1.81 - 9.84)。这些结果表明,皮肤发育异常痣是葡萄膜黑色素瘤的一个重要风险因素。

相似文献

1
Dysplastic nevi are a risk factor for uveal melanoma.发育异常痣是葡萄膜黑色素瘤的一个危险因素。
Eur J Ophthalmol. 1996 Oct-Dec;6(4):472-4. doi: 10.1177/112067219600600423.
2
Are atypical nevi a risk factor for uveal melanoma? A case-control study.非典型痣是葡萄膜黑色素瘤的危险因素吗?一项病例对照研究。
J Invest Dermatol. 1994 Aug;103(2):202-5. doi: 10.1111/1523-1747.ep12392754.
3
[Connection between uveal melanoma and dysplastic naevus syndrome].[葡萄膜黑色素瘤与发育异常痣综合征之间的关联]
Magy Onkol. 2005;49(1):15-8. Epub 2005 May 18.
4
Cutaneous dysplastic naevi: risk factor for uveal melanoma.皮肤发育异常痣:葡萄膜黑色素瘤的危险因素。
Lancet. 1995 Jul 22;346(8969):255-6. doi: 10.1016/s0140-6736(95)91305-x.
5
Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.眼黑色素瘤:流行病学、临床表现及与发育异常痣的关系。
Ophthalmologica. 2004 Mar-Apr;218(2):111-4. doi: 10.1159/000076146.
6
Lack of association between intraocular melanoma and cutaneous dysplastic nevi.眼内黑色素瘤与皮肤发育异常痣之间无关联。
Am J Ophthalmol. 1984 Oct 15;98(4):478-82. doi: 10.1016/0002-9394(84)90135-1.
7
Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.1 型肌强直性营养不良患者的发育不良痣、皮肤黑素瘤和其他皮肤肿瘤:一项横断面研究。
J Am Acad Dermatol. 2015 Jan;72(1):85-91. doi: 10.1016/j.jaad.2014.09.038. Epub 2014 Nov 5.
8
Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma.发育异常痣在确定非家族性黑色素瘤风险方面与痣总数的独立性。
Prev Med. 1988 May;17(3):273-9. doi: 10.1016/0091-7435(88)90003-5.
9
Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects.黑色素瘤患者及对照受试者中临床非典型(发育异常)痣的人口统计学研究。
Cancer Res. 1985 Apr;45(4):1855-61.
10
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.临床诊断的发育异常痣。皮肤黑色素瘤的一个主要危险因素。
JAMA. 1997 May 14;277(18):1439-44.

引用本文的文献

1
The roles of genetic mutation and cytokines/chemokines in immune response and their association with uveal melanoma patient outcome.基因突变和细胞因子/趋化因子在免疫反应中的作用及其与葡萄膜黑色素瘤患者预后的关联。
Heliyon. 2024 Sep 11;10(18):e37852. doi: 10.1016/j.heliyon.2024.e37852. eCollection 2024 Sep 30.
2
The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma.免疫检查点 VISTA 与恶性葡萄膜黑色素瘤患者的预后相关。
Front Immunol. 2023 Aug 18;14:1225140. doi: 10.3389/fimmu.2023.1225140. eCollection 2023.
3
Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications.
葡萄膜黑色素瘤的遗传和表观遗传特征——概述及临床意义。
Int J Mol Sci. 2023 Aug 15;24(16):12807. doi: 10.3390/ijms241612807.
4
Clinical features and treatment outcomes of progressive uveal melanoma.进行性葡萄膜黑色素瘤的临床特征及治疗结果
Arch Clin Cases. 2023 Jun 23;10(2):102-106. doi: 10.22551/2023.39.1002.10251. eCollection 2023.
5
Global Incidence and Trend of Uveal Melanoma from 1943-2015: A Meta-Analysis.全球 1943-2015 年葡萄膜黑色素瘤的发病率和趋势:一项荟萃分析。
Asian Pac J Cancer Prev. 2022 May 1;23(5):1791-1801. doi: 10.31557/APJCP.2022.23.5.1791.
6
Targeting Oncogenic Gα in Uveal Melanoma.靶向葡萄膜黑色素瘤中的致癌Gα
Cancers (Basel). 2021 Dec 9;13(24):6195. doi: 10.3390/cancers13246195.
7
Uveal melanoma diagnosis and current treatment options (Review).葡萄膜黑色素瘤的诊断与当前治疗选择(综述)
Exp Ther Med. 2021 Dec;22(6):1428. doi: 10.3892/etm.2021.10863. Epub 2021 Oct 11.
8
Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.通过液体活检生物标志物检测循环肿瘤 DNA 中的驱动突变对葡萄膜黑色素瘤的跟踪研究。
J Exp Clin Cancer Res. 2021 Jun 16;40(1):196. doi: 10.1186/s13046-021-01984-w.
9
Hypoxia-dependent drivers of melanoma progression.缺氧依赖性的黑色素瘤进展驱动因素。
J Exp Clin Cancer Res. 2021 May 8;40(1):159. doi: 10.1186/s13046-021-01926-6.
10
Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours.眼部肿瘤不同治疗期间及/或之后发生的医源性眼表疾病。
Cancers (Basel). 2021 Apr 16;13(8):1933. doi: 10.3390/cancers13081933.